Description
(R)-Zunsemetinib is the isomer of Zunsemetinib, and can be used as an experimental control. Zunsemetinib (CDD-450) is an orally active and selective p38α mitogen-activated protein kinase-activated protein kinase 2 ( MK2 ) pathway inhibitor. Zunsemetinib can be used for the research of immuno-inflammatory diseases